Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer

Published:2024-03-05 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Zhang Honghu¹,Qi Lin¹,Cai Yi¹^ORCID,Gao Xiaomei²

Affiliation:

1. Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha City, P. R. China

2. Department of Pathology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha City, P. R. China

Funder

Key Research and Development Program of Hunan Province of China

National Natural Science Foundation of China

the clinical research foundation of the National Clinical Research Center for Geriatric Diseases

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2320301

Reference97 articles.

1. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

2. Screening for prostate cancer: US preventive services task force recommendation statement;Grossman DC;JAMA,2018

3. PSMA PET imaging in the diagnosis and management of prostate cancer

4. Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R

5. 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP